Differential formation of prostacyclin (PGX or PGI2) by layers of the arterial wall. An explanation for the anti-thrombotic properties of vascular endothelium.
D000818:Animals; D001013:Aorta, Thoracic; D001095:Arachidonic Acids / Q000494:pharmacology; D004727:Endothelium / Q000166:cytology / Q000201:enzymology; D011464:Epoprostenol / Q000096:biosynthesis*; D005343:Fibrinolytic Agents; D007213:Indomethacin / Q000494:pharmacology; D010974:Platelet Aggregation; D011453:Prostaglandins / Q000096:biosynthesis*; D011463:Prostaglandins H / Q000378:metabolism; D011817:Rabbits
D001095:Arachidonic Acids; D005343:Fibrinolytic Agents; D011453:Prostaglandins; D011463:Prostaglandins H; D011464:Epoprostenol; D007213:Indomethacin